Cargando…

ALKing the flames of lung cancer immunosensitivity

Immune checkpoint inhibitors (ICIs) are utilised in treating non‐small cell lung cancer (NSCLC) by enhancing the immune response against cancer cells. However, they are not effective against cancers with certain genetic alterations. A recent study by Mota et al. focussed on understanding why ALK+ NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayliss, Richard, Sarnowska, Elżbieta, Yeoh, Sharon, Sampson, Josephina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620113/
https://www.ncbi.nlm.nih.gov/pubmed/37795653
http://dx.doi.org/10.1002/1878-0261.13533

Ejemplares similares